Nano4Glio

Engineered nano-based device for glioblastoma multiforme therapy

Work Packages

Nano4Glio aims to develop a novel biodegradable implantable device for GBM therapy, able to overcome the limitations of currently available treatments. The methodology that will be adopted to achieve this goal is divided into 6 work packages (WP).

WP 1 - Project management and coordination

Leader: FEUP

Partners involved: All partners

Start date: 1

End date: 36

WP 3 - Incorporation of the NPs into the hydrogel: design and production

Leader: SINTEF

Partners involved: FEUP

Start date: 8

End date: 36

WP 5 - In vivo safety and efficacy studies of the implantable device in a mouse model

Leader: i3S

Partners involved: FEUP, SINTEF

Start date: 25

End date: 36

WP 2 - NPs for drug delivery: design, production, and optimization

Leader: FEUP

Partners involved: SINTEF

Start date: 1

End date: 36

WP 4 - Study of in vitro biological performance of the developed materials and preliminary pharmacokinetic study in mice

Leader: UCPH

Partners involved: All partners

Start date: 8

End date: 25

WP 6 - Dissemination and exploitation of the results

Leader: FEUP

Partners involved: All partners

Start date: 1

End date: 36

Engineered nano-based device for glioblastoma multiforme therapy

Work Packages

WP 1 - Project management and coordination

​

​

WP 3 - Incorporation of the NPs into the hydrogel: design and production

​

​

WP 5 - In vivo safety and efficacy studies of the implantable device in a mouse model

​

​

WP 2 - NPs for drug delivery: design, production, and optimization

​

WP 4 - Study of in vitro biological performance of the developed materials and preliminary pharmacokinetic study in mice

​

​

WP 6 - Dissemination and exploitation of the results

​

​